Takeda Pharmaceutical (TAK) Prepaid Assets (2017 - 2026)
Takeda Pharmaceutical's (TAK) quarterly Prepaid Assets came in at $1.0 billion in Q1 2026, down 0.87% year-on-year from $1.0 billion in Q1 2025, and down 9.21% quarter-over-quarter from $1.1 billion in Q4 2025.
Takeda Pharmaceutical (TAK) Prepaid Assets (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Prepaid Assets history runs 10 years deep, the most recent figure standing at $1.0 billion for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 0.87% year-over-year to $1.0 billion in Q1 2026; TTM through Mar 2026 was $1.0 billion, a 0.87% decrease from a year earlier, with the FY2026 full-year figure at $1.1 billion, up 3.12% from the prior year.
- Prepaid Assets slipped to $1.0 billion in Q1 2026 per TAK's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.3 billion in Q2 2023 and bottomed at $1.0 billion in Q1 2026.
- The 5-year median for Prepaid Assets is $1.2 billion (2024), against an average of $1.2 billion.
- Across the five-year window, Prepaid Assets advanced 10.74% in 2023 and fell 12.42% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $1.1 billion in 2022, then gained by 10.74% to $1.2 billion in 2023, then fell by 2.84% to $1.2 billion in 2024, then declined by 3.13% to $1.1 billion in 2025, then declined by 9.21% to $1.0 billion in 2026.
- Per Business Quant, the three latest TAK Prepaid Assets figures stand at $1.0 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.13 Bn |
| Jun 30, 2025 | 1.20 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.18 Bn |
| Sep 30, 2024 | 1.08 Bn |
| Jun 30, 2024 | 1.27 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 1.21 Bn |
| Sep 30, 2023 | 1.23 Bn |
| Jun 30, 2023 | 1.31 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.10 Bn |
| Sep 30, 2022 | 1.13 Bn |
| Jun 30, 2022 | 1.26 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.22 Bn |
| Sep 30, 2021 | 1.20 Bn |
| Jun 30, 2021 | 1.22 Bn |